Vanguard Personalized Indexing Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.39M | Buy |
34,928
+13,226
| +61% | +$1.66M | 0.05% | 330 |
|
|
2025
Q1 | $2.97M | Buy |
21,702
+44
| +0.2% | +$6.02K | 0.04% | 365 |
|
|
2024
Q4 | $3.31M | Buy |
21,658
+10,359
| +92% | +$1.58M | 0.05% | 325 |
|
|
2024
Q3 | $2.19M | Sell |
11,299
-1,962
| -15% | -$380K | 0.04% | 445 |
|
|
2024
Q2 | $3.07M | Buy |
13,261
+2,855
| +27% | +$662K | 0.06% | 291 |
|
|
2024
Q1 | $2.24M | Buy |
10,406
+200
| +2% | +$43.1K | 0.05% | 362 |
|
|
2023
Q4 | $2.64M | Sell |
10,206
-525
| -5% | -$136K | 0.07% | 271 |
|
|
2023
Q3 | $2.76M | Sell |
10,731
-619
| -5% | -$159K | 0.08% | 236 |
|
|
2023
Q2 | $3.23M | Buy |
11,350
+1,236
| +12% | +$352K | 0.1% | 196 |
|
|
2023
Q1 | $2.81M | Buy |
10,114
+909
| +10% | +$253K | 0.1% | 206 |
|
|
2022
Q4 | $2.55M | Buy |
9,205
+1,938
| +27% | +$537K | 0.11% | 193 |
|
|
2022
Q3 | $1.94M | Buy |
7,267
+1,389
| +24% | +$371K | 0.09% | 237 |
|
|
2022
Q2 | $1.2M | Buy |
5,878
+2,704
| +85% | +$552K | 0.06% | 377 |
|
|
2022
Q1 | $668K | Buy |
3,174
+1,022
| +47% | +$215K | 0.03% | 672 |
|
|
2021
Q4 | $516K | Sell |
2,152
-821
| -28% | -$197K | 0.03% | 693 |
|
|
2021
Q3 | $841K | Buy |
2,973
+339
| +13% | +$95.9K | 0.08% | 280 |
|
|
2021
Q2 | $912K | Buy |
2,634
+1,212
| +85% | +$420K | 0.1% | 231 |
|
|
2021
Q1 | $398K | Buy |
1,422
+239
| +20% | +$66.9K | 0.06% | 397 |
|
|
2020
Q4 | $290K | Buy |
1,183
+141
| +14% | +$34.6K | 0.06% | 385 |
|
|
2020
Q3 | $296K | Buy |
1,042
+188
| +22% | +$53.4K | 0.08% | 292 |
|
|
2020
Q2 | $228K | Sell |
854
-345
| -29% | -$92.1K | 0.1% | 263 |
|
|
2020
Q1 | $379K | Buy |
+1,199
| New | +$379K | 0.22% | 129 |
|